`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`MYLAN PHARMACEUTICALS INC,
`Petitioner,
`
`v.
`
`MERCK SHARP & DOHME CORP.,
`Patent Owner.
`__________________
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`__________________
`
`UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF ALEXANDER S.
`ZOLAN PURSUANT TO 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`I.
`
`RELIEF REQUESTED
`
`Pursuant to 37 C.F.R. § 42.10(c) and the Board’s Notice of Filing Date Accorded to
`
`Petition and Time for Filing Patent Owner Preliminary Response, which authorizes the parties to
`
`file motions for pro hac vice admission, Paper 4 at 2, Patent Owner Merck Sharp & Dohme
`
`Corp. submits the following motion for admission pro hac vice of Alexander S. Zolan of
`
`Williams & Connolly LLP, 725 Twelfth Street, N.W., Washington, DC 20005 in the above-
`
`captioned matter.
`
`II.
`
`GOVERNING LAW, RULES, AND PRECEDENT
`
`The Board is authorized to recognize counsel pro hac vice pursuant to 37 C.F.R.
`
`§ 42.10(c), which provides that:
`
`The Board may recognize counsel pro hac vice during a proceeding upon a
`
`showing of good cause, subject to the condition that lead counsel be a
`
`registered practitioner and to any other conditions as the Board may impose.
`
`For example, where the lead counsel is a registered practitioner, a motion
`
`to appear pro hac vice by counsel who is not a registered practitioner may
`
`be granted upon showing that counsel is an experienced litigating attorney
`
`and has an established familiarity with the subject matter at issue in the
`
`proceeding.
`
`The Unified Patents Order requires that a pro hac vice motion “[c]ontain a statement of
`
`facts showing there is good cause for the Board to recognize counsel pro hac vice during the
`
`proceeding.” Order – Authorizing Motion for Pro Hac Vice Admission – 37 C.F.R. § 42.10,
`
`IPR2013-00639, Paper 7 at 3. A motion for pro hac vice admission should also be accompanied
`
`by an affidavit or declaration of the individual seeking to appear attesting to the following:
`
`i. Membership in good standing of the Bar of at least one State or the District of
`
`Columbia;
`
`
`
`2
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`ii. No suspensions or disbarments from practice before any court or
`
`administrative body;
`
`iii. No application for admission to practice before any court or administrative
`
`body ever denied;
`
`iv. No sanctions or contempt citations imposed by any court or administrative
`
`body;
`
`v. The individual seeking to appear has read and will comply with the Office
`
`Patent Trial Practice Guide and the Board’s Rules of Practice for Trials set
`
`forth in part 42 of 37 C.F.R.;
`
`vi. The individual will be subject to the USPTO Rules of Professional Conduct
`
`set forth in 37 C.F.R. §§ 11.101 et seq.;
`
`vii. All other proceedings before the Office for which the individual has applied to
`
`appear pro hac vice in the last three (3) years; and
`
`viii.
`
`Familiarity with the subject matter at issue in the proceeding.
`
`Id.
`
`III.
`
`STATEMENT OF FACTS
`
`Based on the following facts, and supported by the Declaration of Mr. Zolan (Ex. 2025)
`
`submitted herewith, Patent Owner Merck Sharp & Dohme Corp. requests the pro hac vice
`
`admission of Alexander S. Zolan in this proceeding:
`
`1. Patent Owner’s lead counsel, Stanley E. Fisher (Reg. No. 55,820), is a registered
`
`practitioner before the Board.
`
`2. Mr. Zolan is a partner at Williams & Connolly LLP and an experienced litigation
`
`attorney. Mr. Zolan has more than seven (7) years of litigation experience. Ex. 2025 ¶ 2.
`
`3. Mr. Zolan has established familiarity with the subject matter at issue in this proceeding.
`
`As detailed below, Mr. Zolan has reviewed in detail the pleadings, patent, and exhibits relied
`
`upon by Petitioner, as well as engaged in extensive strategic and substantive discussions
`
`regarding this proceeding with Stanley E. Fisher, the lead counsel for Patent Owner Merck Sharp
`
`
`
`3
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`& Dohme Corp. Ex. 2025 ¶ 10. Mr. Zolan has engaged in the representation of Patent Owner
`
`Merck Sharp & Dohme Corp. in related matters in federal district court, including the assertion
`
`of U.S. Patent No. 7,326,708 in Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc.,
`
`C.A. No. 19-cv-101-IMK (N.D.W.V.) and In Re: Sitagliptin Patent Litigation, MDL No. 19-
`
`2902-RGA (D. Del.) (consolidated). Ex. 2025 ¶ 10.
`
`4. Mr. Zolan has also reviewed in detail relevant case law and legal authority related to the
`
`allegations made in the Petition. Ex. 2025 ¶ 11.
`
`5. Mr. Zolan is a member in good standing of the bars of New York and the District of
`
`Columbia. Ex. 2025 ¶ 3.
`
`6. Mr. Zolan has never been suspended or disbarred from practice before any court or
`
`administrative body. Ex. 2025 ¶ 4.
`
`7. No court or administrative body has ever denied Mr. Zolan’s application for admission to
`
`practice before it. Ex. 2025 ¶ 5.
`
`8. No court or administrative body has ever imposed sanctions or contempt citations on Mr.
`
`Zolan. Ex. 2025 ¶ 6.
`
`9. Mr. Zolan has read and will comply with the Office Patent Trial Practice Guide and the
`
`Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R. Ex. 2025 ¶ 7.
`
`10. Mr. Zolan understands that he will be subject to the USPTO Rules of Professional
`
`Conduct set forth in 37 C.F.R. §§ 11.101 et seq. Ex. 2025 ¶ 8.
`
`11. Mr. Zolan is seeking pro hac vice admission to appear in the Petitioner’s inter partes
`
`challenge to U.S. Patent No. 7,326,708. That proceeding has been designated Case No.
`
`IPR2020-00040. Within the last three (3) years, Mr. Zolan has applied to appear pro hac vice in
`
`one (1) other proceeding before the Office. See Argentum Pharms, LLC v. Alcon Research,
`
`
`
`4
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`LTD., IPR2017-01053, Paper 11 (P.T.A.B. Oct. 16, 2017). Mr. Zolan’s application was granted.
`
`Id. at Paper 15; Ex. 2025 ¶ 9.
`
`IV. GOOD CAUSE EXISTS FOR THE PRO HAC VICE ADMISSION OF MR.
`ZOLAN IN THIS PROCEEDING
`
`
`
`The Board may recognize counsel pro hac vice during a proceeding upon a showing of
`
`good cause, subject to the condition that lead counsel be a registered practitioner and to any other
`
`conditions as the Board may impose. 37 C.F.R. § 42.10(c). Patent Owner’s lead counsel,
`
`Stanley E. Fisher, is a registered practitioner before the Board. Based on the facts contained
`
`herein, as supported by Mr. Zolan’s declaration, good cause exists to admit Mr. Zolan pro hac
`
`vice in this proceeding.
`
`As set forth in his declaration, Mr. Zolan is a partner at Williams & Connolly LLP and an
`
`experienced litigator with more than seven (7) years of litigation experience. Ex. 2025 ¶ 2.
`
`Mr. Zolan has established familiarity with the subject matter at issue in the proceeding.
`
`Ex. 2025 ¶ 10. Mr. Zolan has reviewed in detail the pleadings submitted by Petitioner in this
`
`proceeding. Ex. 2025 ¶ 10. Mr. Zolan has reviewed in detail the challenged patent. Ex. 2025 ¶
`
`10. Mr. Zolan has also reviewed in detail exhibits relied upon by Petitioner, such as Exhibit
`
`1002 (Declaration of Dr. Mukund Chorghade, Ph.D.). Ex. 2025 ¶ 10.
`
`Mr. Zolan has engaged in extensive strategic and substantive discussions regarding this
`
`proceeding with Stanley E. Fisher, who is the lead counsel for the Patent Owner in this case. Ex.
`
`2025 ¶ 10. Mr. Zolan has engaged in the representation of Patent Owner Merck Sharp & Dohme
`
`Corp. in related matters in federal district court, including the assertion of U.S. Patent No.
`
`7,326,708 in Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., C.A. No. 19-cv-101-
`
`IMK (N.D.W.V.) and In Re: Sitagliptin Patent Litigation, MDL No. 19-2902-RGA (D. Del.)
`
`
`
`5
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`(consolidated). Ex. 2025 ¶ 10. Mr. Zolan has reviewed in detail relevant case law and other
`
`legal authority related to the allegations made in the Petition. Ex. 2025 ¶ 11.
`
`In view of Mr. Zolan’s knowledge of the subject matter at issue in this proceeding, Patent
`
`Owner Merck Sharp & Dohme Corp. has a substantial need for Mr. Zolan’s pro hac vice
`
`admission and his involvement in the continued prosecution of this proceeding.
`
`Petitioner does not oppose this motion.
`
`CONCLUSION
`
`V.
`
`
`For the foregoing reasons, Patent Owner Merck Sharp & Dohme Corp. respectfully
`
`requests that Mr. Zolan be admitted pro hac vice in this proceeding.
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees associated
`
`with this filing to Deposit Account No. 501290.
`
`
`
`Date: May 18, 2020
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Stanley E. Fisher/
`Stanley E. Fisher (Reg. No. 55,820)
`Bruce R. Genderson (Pro Hac Vice)
`Jessamyn S. Berniker (Reg. No. 72,328)
`Elise M. Baumgarten
`(Pro Hac Vice Motion pending)
`Alexander S. Zolan
`(Pro Hac Vice Motion pending)
`Shaun P. Mahaffy (Reg. No. 75,534)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`sfisher@wc.com
`bgenderson@wc.com
`jberniker@wc.com
`ebaumgarten@wc.com
`azolan@wc.com
`
`6
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`smahaffy@wc.com
`asheh@wc.com
`
`Counsel for Patent Owner
`Merck Sharp & Dohme Corp.
`
`
`
`
`
`7
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true and correct
`
`copy of the foregoing was served on May 18, 2020, by delivering a copy via electronic mail on
`
`the following attorneys of record:
`
`Jitendra Malik
`Alissa M. Pacchioli
`Christopher W. West
`Heike S. Radeke
`KATTEN MUCHIN ROSEMAN LLP
`550 South Tryon, Street Suite 2900
`Charlotte, NC 28202-4213
`(704) 444-2000
`jitty.malik@kattenlaw.com
`alissa.pacchioli@kattenlaw.com
`christopher.west@katten.com
`heike.radeke@katten.com
`
`
`
`/Anthony H. Sheh/
`Anthony H. Sheh
`Reg. No. 70,576
`
`
`
`
`8
`
`
`
`
`
`
`
`
`
`
`